Pharmacokinetics, therapeutic efficacy, and prolonged residue depletion of flumequine in Japanese eel (Anguilla japonica) and its implications for withdrawal period determination | Synapse
March 3, 2026
Pharmacokinetics, therapeutic efficacy, and prolonged residue depletion of flumequine in Japanese eel (Anguilla japonica) and its implications for withdrawal period determination
Puntos clave
Therapeutic efficacy of flumequine was demonstrated in Japanese eel, impacting treatment protocols.
Flumequine exhibited a prolonged residue depletion of 31 days post-treatment, indicating safety concerns.
Assessment included drug absorption, distribution, metabolism, and excretion analyses across numerous trials.
Highlights the need for careful withdrawal period determination to ensure consumer safety and regulatory compliance.